Health groups issue proposed cervical cancer screening guidelines

October 19, 2011 in Cancer

The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have proposed new guidelines for the prevention and early detection of cervical cancer. The proposed guidelines, which are now posted for public comment, generally advise that women reduce the number of tests they get over their lifetime to better ensure that they receive the benefits of testing while minimizing the risks. The proposed guidelines also include a preference for co-testing using the Pap test and HPV test for women age 30 and over. After a public comment period that begins immediately and a multi-stakeholder symposium in November to discuss the proposed recommendations among a broad group of experts, the recommendations will be revised and incorporated into a final guideline from the American Cancer Society, anticipated in mid-2012.

The proposed guidelines were released on the same day that the U.S. Task Force (USPSTF) formally released its proposed guidelines update for cervical cancer screening. ACS, ASCCP and ASCP worked independently of the USPSTF to review existing evidence and develop these draft recommendations. The groups coordinated today's release with the USPSTF to enable stakeholders to consider both sets of recommendations concurrently with the goal of creating consistent guidance that will lead to less confusion for providers and the public.

The ACS-ASCCP-ASCP proposed guidelines would include some changes from the current ACS guidelines.

  • They would recommend that all women start screening at age 21, and drop the recommendation that women under 21 begin screening three years after starting .
  • They propose that for women 21 to 29, Pap tests (conventional or liquid-based) be done every three years, and recommends against annual Pap testing. Current guidelines call for a conventional Pap test every year, or a liquid-based Pap test every two years for this age group.
  • For women 30 and over, the guidelines propose that Pap tests be done every three years, recommending against annual or more frequent Pap testing. Current guidelines say women 30 and over who have had three normal Pap tests in a row may be tested less often, every two to three years.
  • The guidelines propose that Pap test plus HPV testing every 3-5 years be the preferred strategy for women aged 30 and older, and recommend against screening with any test or combination of tests more often than every three years. Current ACS guidelines call for testing no more frequently than every three years with a Pap test plus the HPV DNA test 'an option' for women over 30 who have normal immune systems and no abnormal Pap results.
  • The proposed recommendations also say screening is not recommended for women 65 or older who have had three or more normal Pap tests in a row and no abnormal Pap test results in the last 10 years, or who had two or more negative HPV tests in the last 10 years. Current guidelines say women may choose to stop being tested at age 70 when they've had three or more normal Pap tests in a row and no abnormal results in the last 10 years.
"These draft recommendations are being presented for review by interested individuals and stakeholders, primarily clinicians and researchers, who are invited to provide feedback through a web-based open comment period," said Debbie Saslow, PhD, director of breast and gynecologic cancer for the . "The six working groups that developed these recommendations will then consider the submitted comments, and make revisions to these proposed recommendations based on that input and available evidence."

Other new recommendations included in the proposed guideline:

  • Women who have a normal Pap result and a positive HPV test result should receive genotyping for HPV 16 and 18 or repeat both the Pap and HPV tests in one year. The proposed guideline recommends against immediate colposcopy.
  • Women having a mildly abnormal Pap result (called ASC-US) and a negative HPV test result should be followed by either HPV testing plus Pap or HPV testing alone at intervals of three years or longer.
  • At this time there is insufficient evidence to recommend for or against a comprehensive program for primary screening with HPV testing alone (with defined follow-up testing) in the US.
  • Women who have been vaccinated against HPV should begin screening at the same age as unvaccinated , i.e. at age 21.
The working groups who drafted the proposed guidelines will meet along with delegates from 25 organizations at a symposium in November 2011 to further discuss and finalize the , which will then be adapted into a final guideline from the American Cancer Society, anticipated in mid-2012.

More information: The proposed recommendations can be reviewed at:

www.asccp.org/prac… ng-symposium

The proposed recommendations from the USPSTF can be viewed at:

www.uspreventivese… fcomment.htm

Provided by American Cancer Society search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 4 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 6 hours ago | popularity not rated yet | comments 0


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Life expectancy gap widens between those with mental illness and general population

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...